A biologic is a medical product made from living cells rather than chemical ingredients mixed in a lab. Unlike conventional drugs, which are relatively small, simple molecules produced through chemical reactions, biologics are large, complex proteins grown inside living systems like bacteria, yeast, or animal cells. This fundamental difference affects everything about them: how they’re made, how they’re given to patients, what they cost, and why they can’t simply be copied like a generic pill.
How Biologics Differ From Standard Drugs
Most medications you pick up at a pharmacy are what scientists call small-molecule drugs. Aspirin, metformin, statins: these have simple chemical structures, predictable behavior in the body, and straightforward manufacturing. You can write out their molecular formula on a napkin.
Biologics are a different class entirely. They’re proteins with intricate three-dimensional shapes, surface patterns, and folding structures that determine whether they work or not. Their molecular weight dwarfs that of a conventional drug. Because of this complexity, their behavior in the body is harder to predict, and dosing protocols tend to be more involved. Manufacturing them requires growing living cells under tightly controlled conditions rather than combining chemicals in a reactor, which makes the process far more expensive and difficult to scale up. Maintaining consistency from one production batch to the next is one of the biggest challenges in biologic manufacturing.
How Biologics Are Made
Production starts with identifying the gene responsible for making the desired protein. That gene is inserted into a vector (essentially a delivery vehicle) and introduced into a host cell, often a line of mammalian or bacterial cells specifically chosen for this purpose. These engineered cells are stored in a master cell bank, a frozen repository that serves as the starting point for every future batch.
When it’s time to produce a batch, cells are thawed, expanded in progressively larger culture vessels, and allowed to grow and secrete the target protein. The mixture is then harvested, and the protein goes through multiple rounds of purification to remove cell debris, unwanted proteins, and contaminants. The final purified protein is formulated into a stable drug product, filtered, and packaged. The entire process can take weeks to months for a single batch, and even small changes in temperature, timing, or cell behavior can affect the final product.
Why Biologics Are Given by Injection or Infusion
You can’t take most biologics as a pill. These are large protein molecules, and your digestive system would break them apart before they ever reached your bloodstream. Proteins are also highly water-soluble, which makes them naturally suited to liquid formulations delivered directly into the body. That’s why biologics are typically given as an injection under the skin, into a muscle, or as an intravenous infusion at a clinic.
Storage is another consideration. Biologics are sensitive to temperature swings, light exposure, and even physical shaking. Heat can cause the protein to unfold and lose its shape, destroying its ability to work. Light can trigger chemical reactions that degrade key parts of the molecule. This is why your biologic medication comes with strict refrigeration instructions and why shipping these products requires careful cold-chain management from factory to pharmacy.
What Biologics Treat
Biologics have transformed treatment for dozens of conditions, particularly diseases driven by an overactive or misdirected immune system. The list of approved uses is long and continues to grow:
- Autoimmune and inflammatory conditions: rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, lupus, and multiple sclerosis
- Cancers: breast cancer (HER2-positive), colorectal cancer, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, cervical cancer, and head and neck cancers
- Other conditions: severe allergic asthma, organ transplant rejection, and RSV prevention in high-risk children
Some of the most widely prescribed biologics include adalimumab (Humira), approved for nine different conditions ranging from rheumatoid arthritis to uveitis, and etanercept (Enbrel), used primarily for arthritis and psoriasis. In oncology, trastuzumab (Herceptin) targets HER2-positive breast cancer, while bevacizumab (Avastin) is used across seven different cancer types.
How Biologics Work in the Body
What makes biologics powerful is their precision. Traditional drugs often affect broad chemical pathways throughout the body. Biologics are designed to lock onto one specific target, usually a protein or receptor involved in driving disease.
In autoimmune diseases, many biologics work by intercepting inflammatory signals. Some block a molecule called TNF, a key driver of inflammation in conditions like rheumatoid arthritis and Crohn’s disease. These TNF blockers either act as decoy receptors that soak up the inflammatory signal before it reaches cells, or they’re antibodies that bind directly to TNF and neutralize it.
Other biologics target different parts of the immune cascade. Some block interleukins, the chemical messengers that amplify inflammation. Others interfere with the activation of T cells, a type of immune cell, by preventing the “second signal” these cells need to switch on. Still others deplete B cells, another class of immune cells implicated in conditions like lupus and certain lymphomas. In cancer, biologics can flag tumor cells for destruction by the immune system or block the growth signals that tumors rely on to spread.
Major Categories of Biologics
The FDA regulates several broad categories of biological products. Monoclonal antibodies, the type most people think of when they hear “biologic,” are engineered antibodies designed to bind a single target. But the category is much wider than that. Vaccines are biologics. So are blood products and blood-derived therapies. Cell and gene therapy products, which introduce new genetic material or living cells into a patient, fall under the biologic umbrella as well. Even human tissue products used in transplantation are regulated as biologics.
Biosimilars: The “Generic” Question
When a patent expires on a conventional drug, other manufacturers can produce an identical generic version. Biologics don’t work that way. Because they’re made from living cells, every manufacturer’s product will have slight, inherent variations in the protein, even between batches from the same manufacturer. You can’t make an exact copy.
Instead, regulators created a category called biosimilars. A biosimilar must be shown to be “highly similar” to the original biologic, with no clinically meaningful differences in safety or effectiveness. Minor differences in inactive components are acceptable. The approval process is more demanding than for a generic pill but less extensive than developing a brand-new biologic from scratch.
Some biosimilars go a step further and earn an interchangeable designation, meaning a pharmacist can substitute them for the original product, much like swapping a brand-name pill for its generic. Biosimilars generally cost less than the original biologic and are expanding access to treatments that were previously out of reach for many patients. Several biosimilars of adalimumab, for instance, are now available, creating competition in a market once dominated by a single product.
What to Expect as a Patient
If you’re prescribed a biologic, the experience looks different from picking up a bottle of pills. Many biologics are self-injected at home using a prefilled syringe or auto-injector pen, typically once every week or two. Others require an infusion at a clinic or hospital, which can take anywhere from 30 minutes to several hours depending on the drug. Your schedule will vary based on the specific biologic and the condition being treated.
Because biologics interact with the immune system, they can increase susceptibility to infections. Your doctor will likely screen you for certain infections before starting treatment and monitor your bloodwork periodically. Some people experience injection-site reactions like redness or swelling, and infusion-related reactions like mild fever or chills can occur during IV administration, particularly with the first few doses. These side effects tend to diminish over time for most people.